OnQ Neuro is FDA-cleared post-processing software used by
radiologists, oncologists, and other clinicians to assist with the analysis and quantification of MR images of brain tumors.
Powered by AI and Advanced Diffusion MRI
Discover the Benefits of OnQ Neuro
Objective Tumor
Volumetrics
Consistent, repeatable, quantitative 3D brain tumor volumetric analysis
Longitudinal Disease Assessment
Automated quantification and tracking of pre- and post-treatment brain tumor volumes across time
Advanced Diffusion
Analysis
Unique insights of brain tumor microstructure using Patented Restriction Spectrum Imaging (RSI) technology.
Clinical Cases
Preoperative High Grade Glioma
Preoperative High Grade Glioma
OnQ Neuro provides slice by slice tumor segmentation in DICOM format for both high grade and low grade gliomas.
Postoperative High Grade Glioma
Postoperative High Grade Glioma
OnQ Neuro Report
Advance Diffusion Analysis with Restriction Spectrum Imaging
Restriction Spectrum Imaging (RSI) is an advanced diffusion MRI technique for quantitative analysis of brain tissue microstructure. RSI utilizes a clinical multi-shell diffusion MRI protocol to differentiate cellular restricted diffusion (a hallmark signature of high-grade cancers) from extracellular hindered and free water.
